PFE Maintained by HSBC -- Price Target Raised to $30
gurufocus.com · 2026-09-10
Pfizer (PFE) Analyst Rating Update - October 2023 On October 4, 2023, HSBC maintained a "Hold" rating on Pfizer (PFE). The price target has been raised from
Read the full story at gurufocus.com →
Is PFE undervalued? See TickrTrends' fair value analysis →